XML 32 R22.htm IDEA: XBRL DOCUMENT v3.25.1

Segment Performance Measures and Expenses (Tables)

3 Months Ended

Mar. 31, 2025

Segment Reporting [Abstract]

Schedule of Significant Expense Categories and Consolidated Net Loss

The table below provides a summary of the significant expense categories and consolidated net loss details provided to the CODM (in thousands):

 Schedule of Significant Expense Categories and Consolidated Net Loss

		For the three months ended March 31,
		(In thousands)								Change Increase (Decrease)
		2025				2024
Operating Expenses:
Clinical Research
OVATION		$	214			$	287			$	(73	)			(25.4	)%
Vaccine			58				571				(513	)			(89.8	)%
Other Clinical and regulatory			574				477				97				20.3	%
Subtotal			846				1,335				(489	)			(36.6	)%
Non-Clinical R&D and CMC
OVATION			913				405				508				125.4	%
PlaCCine Vaccine			-				1,215				(1,215	)			-	%
Manufacturing (CMC)			406				339				67				19.8	%
Subtotal			1,319				1,959				(640	)			(32.7	)%
Research and development expenses			2,165				3,294				(1,129	)			(34.3	)%
General and administrative expenses			1,980				1,717				263				15.3	%
Total operating expenses			4,145				5,011				(866	)			(17.3	)%
Loss from operations		$	(4,145	)		$	(5,011	)		$	(866	)			(17.3	)%

X

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-25

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-30

+ Details

Name:	us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration